Opinion
Video
Clinical insights on the role of a multidisciplinary team in the treatment of kidney cancer and how multidisciplinary care has evolved.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Survey: New NMIBC treatments face slow uptake
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
ADAM, a long-term, injectable male birth control, shows promise at AUA 2025
TikTok, social media does more harm than good for prostate cancer education
Sintilimab plus fruquintinib under review in China for advanced renal cell carcinoma
Data supports mitomycin plus BCG as alternative to BCG alone in NMIBC
Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC
GLP-1 agonist use is rising in men with prostate cancer